PBPHvsXLVETF Comparison
ETF 1
PBPH
Portfolio Building Block World Pharma and Biotech Index ETF
This fund is part of
DM Large & Mid Cap
+0.48%
VS
Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) belongs to the DM Large & Mid Cap segment. State Street Health Care Select Sector SPDR ETF (XLV) is part of the US Health Care segment. PBPH's top 1 sector exposures are Healthcare. In contrast, XLV's top sector exposures are Healthcare and Consumer Non-Cyclicals. PBPH is more expensive with a Total Expense Ratio (TER) of 0.13%, versus 0.08% for XLV. PBPH is up 10.08% year-to-date (YTD) with +$968M in YTD flows. XLV performs worse with 7.78% YTD performance, and +$740M in YTD flows. Run a side-by-side ETF comparison of PBPH and XLV below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
PBPH vs XLV performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 09/11/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | PBPH XLV | -0.72%-1.56% | +7.13%+7.84% | +10.08%+7.78% | n/a+20.47% | n/a+30.79% | n/a+35.50% |
| Flows | PBPH XLV | +$35M-$197M | +$139M+$909M | +$968M+$740M | -+$1.68B | --$5.40B | -+$1.77B |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | PBPH XLV | +20.50%+19.44% | n/a+16.18% | n/a+14.73% | n/a+15.18% |
| Max drawdown | PBPH XLV | -6.59%-5.81% | n/a-10.51% | n/a-17.05% | n/a-17.05% |
| Max drawdown duration | PBPH XLV | 17d23d | n/a116d | n/a444d | n/a444d |
Trading data
PBPH | XLV | |
Last sale 9/14/2026 at 1:30 PM | $28.19 | $167.73 |
| Previous close 09/11/2026 | $27.80 | $165.36 |
| Consolidated volume 09/11/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of August 31, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
PBPH | XLV | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 9/14/2026 at 1:30 PM
Live
Closed
PBPH | XLV | |
|---|---|---|
| Last price | $28.19 | $167.73 |
| 1D performance | +1.39% | +1.43% |
| AuM | $1.01 B | $43.09 B |
| E/R | 0.13% | 0.08% |
Characteristics
PBPH | XLV | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | Tidal | State Street Investment Management |
| Benchmark | BITA Global Pharma and Biotech Select Index | S&P Health Care Select Sector Index |
| N° of holdings | 52 | 59 |
| Asset class | - | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | November 24, 2025 | December 16, 1998 |
| ESG | No | No |
Advertisement
Exposure
Countries
PBPH
USA
65.24%
Switzerland
10.52%
United Kingdom
7.15%
Other
17.09%
XLV
USA
97.53%
Other
2.47%
Sectors
PBPH
Healthcare
99.46%
Other
0.54%
XLV
Healthcare
97.51%
Other
2.49%
Advertisement
Diversification
PBPH
Total weight of top 15 holdings out of 15
75.4%
XLV
Total weight of top 15 holdings out of 15
71.77%
Top 15 holdings
Data as of July 31, 2026
PBPH
Eli Lilly & Co.
15.14%
Johnson & Johnson
9.55%
AbbVie, Inc.
7.06%
Merck & Co., Inc.
4.97%
Roche Holding AG
4.70%
Amgen, Inc.
4.62%
Novartis AG
4.45%
AstraZeneca PLC
3.88%
Gilead Sciences, Inc.
3.77%
Novo Nordisk A/S
3.75%
Pfizer Inc.
3.28%
Bristol Myers Squibb Co.
3.06%
Vertex Pharmaceuticals, Inc.
2.82%
GSK Plc
2.24%
Sanofi
2.10%
XLV
Eli Lilly & Co.
15.48%
Johnson & Johnson
10.51%
AbbVie, Inc.
7.55%
UnitedHealth Group, Inc.
6.41%
Merck & Co., Inc.
5.48%
Thermo Fisher Scientific, Inc.
3.64%
Amgen, Inc.
3.54%
Abbott Laboratories
3.14%
Gilead Sciences, Inc.
2.75%
Pfizer Inc.
2.43%
Bristol Myers Squibb Co.
2.27%
CVS Health Corp.
2.27%
Intuitive Surgical, Inc.
2.13%
Danaher Corp.
2.09%
Vertex Pharmaceuticals, Inc.
2.06%
Frequently asked questions about PBPH and XLV
How have the PBPH and XLV ETFs performed in 2026?
As of September 11, 2026, PBPH is up 10.08% year-to-date (YTD), while XLV has returned 7.78%. That puts PBPH better performer ahead so far this year.
Which ETF is attracting more investor money: PBPH or XLV?
Year-to-date, the PBPH ETF saw +$968M in flows, compared to +$740M for XLV.
Which ETF is bigger: PBPH or XLV?
As of September 11, 2026, PBPH holds $1.01 B in assets under management (AUM), while XLV manages $43.09 B.
What sectors do the PBPH and XLV ETFs invest in?
PBPH leans toward sectors like Healthcare. Meanwhile, XLV focuses on Healthcare.
What are the top holdings of the PBPH ETF and XLV ETF?
PBPH top holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc.. XLV holds in its top three: Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..
Which ETF is more diversified: PBPH or XLV?
PBPH holds 53 securities with 75.4% of its assets in the top 15. XLV has 59 securities and a top 15 weight of 71.77%.
Advertisement
Latest news about PBPH & XLV
ETF Model Portfolios: The Cockroach Portfolio
March 20, 2026
XLV
ETF Central's Guide to Defensive Sector Investing
March 13, 2026
XLV
Chinese Artificial Intelligence (AI) DeepSeek: ETF Winners & Losers
January 27, 2025
XLV
Investing in Sector ETFs: Consumer Staples, Healthcare, & Utilities
August 21, 2024
XLV
Advertisement
Healthcare Stocks Drop on Medicare Payment Rate Surprise
April 8, 2024
XLV
Healthcare Stocks Drop on Medicare Payment Rate Surprise
April 8, 2024
XLV
Advertisement
